These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA. Luo H; Wei W; Ye Z; Zheng J; Xu RH Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194 [TBL] [Abstract][Full Text] [Related]
4. Quantification method of ctDNA using cell-free DNA methylation profile for noninvasive screening and monitoring of colon cancer. Ryu H; Kim JH; Kim YJ; Jeon H; Kim BC; Jeon Y; Kim Y; Bak H; Kang Y; Kim C; Um H; Ahn JH; Hyun H; Kim BC; Song I; Jeon S; Bhak J; Han EC Clin Epigenetics; 2024 Jul; 16(1):95. PubMed ID: 39030645 [TBL] [Abstract][Full Text] [Related]
5. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study. Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158 [TBL] [Abstract][Full Text] [Related]
6. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review. Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754 [TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management. Wang B; Wang M; Lin Y; Zhao J; Gu H; Li X Clin Chem Lab Med; 2024 Oct; 62(11):2111-2127. PubMed ID: 38443752 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential. Bjerre MT; Nørgaard M; Larsen OH; Jensen SØ; Strand SH; Østergren P; Fode M; Fredsøe J; Ulhøi BP; Mortensen MM; Jensen JB; Borre M; Sørensen KD Cells; 2020 May; 9(6):. PubMed ID: 32486483 [TBL] [Abstract][Full Text] [Related]
10. COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCR. Overs A; Peixoto P; Hervouet E; Molimard C; Monnien F; Durand J; Guittaut M; Vienot A; Viot J; Herfs M; Borg C; Feugeas JP; Selmani Z Clin Epigenetics; 2024 Oct; 16(1):146. PubMed ID: 39425144 [TBL] [Abstract][Full Text] [Related]
11. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer. Shields MD; Chen K; Dutcher G; Patel I; Pellini B Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012272 [TBL] [Abstract][Full Text] [Related]
12. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel. Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387 [TBL] [Abstract][Full Text] [Related]
13. Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal tracking. Cresswell GD; Nichol D; Spiteri I; Tari H; Zapata L; Heide T; Maley CC; Magnani L; Schiavon G; Ashworth A; Barry P; Sottoriva A Nat Commun; 2020 Mar; 11(1):1446. PubMed ID: 32221288 [TBL] [Abstract][Full Text] [Related]
14. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection. Symonds EL; Pedersen SK; Murray DH; Jedi M; Byrne SE; Rabbitt P; Baker RT; Bastin D; Young GP Clin Epigenetics; 2018; 10():63. PubMed ID: 29796114 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis. Parisi C; Mastoraki S; Markou A; Strati A; Chimonidou M; Georgoulias V; Lianidou ES Clin Chim Acta; 2016 Oct; 461():156-64. PubMed ID: 27510924 [TBL] [Abstract][Full Text] [Related]
17. The potential of liquid biopsy in the management of cancer patients. Markou A; Tzanikou E; Lianidou E Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850 [TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer. Arisi MF; Dotan E; Fernandez SV Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457259 [TBL] [Abstract][Full Text] [Related]
19. Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer. Zhang X; Hou H; Jiang M; Zhang X Mol Biol Rep; 2023 Mar; 50(3):2743-2750. PubMed ID: 36583782 [TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time? Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]